Daniel A. Cartwright, CFO at TherapeuticsMD, Inc. (TXMD), sold 40,000 shares at $4.57 ($183K) on 2018-12-06, disclosed to the SEC on 2018-12-10.
Open-market sale of $183k TXMD by CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |